Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Patrick Danoy is active.

Publication


Featured researches published by Patrick Danoy.


Scopus | 2011

Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility

David Evans; Alexander Dilthey; M. Pirinen; Tetyana Zayats; C. C. A. Spencer; Z. Su; Céline Bellenguez; Colin Freeman; Amy Strange; Gilean McVean; Peter Donnelly; J. J. Pointon; David Harvey; L. H. Appleton; T. Wordsworth; Tugce Karaderi; C Farrar; Paul Bowness; B. P. Wordsworth; Grazyna Kochan; U. Opperman; M Stone; L. Moutsianis; Stephen Leslie; Tony J. Kenna; Gethin P. Thomas; Linda A. Bradbury; Patrick Danoy; Matthew A. Brown; M. Ward

Ankylosing spondylitis is a common form of inflammatory arthritis predominantly affecting the spine and pelvis that occurs in approximately 5 out of 1,000 adults of European descent. Here we report the identification of three variants in the RUNX3, LTBR-TNFRSF1A and IL12B regions convincingly associated with ankylosing spondylitis (P < 5 × 10−8 in the combined discovery and replication datasets) and a further four loci at PTGER4, TBKBP1, ANTXR2 and CARD9 that show strong association across all our datasets (P < 5 × 10−6 overall, with support in each of the three datasets studied). We also show that polymorphisms of ERAP1, which encodes an endoplasmic reticulum aminopeptidase involved in peptide trimming before HLA class I presentation, only affect ankylosing spondylitis risk in HLA-B27–positive individuals. These findings provide strong evidence that HLA-B27 operates in ankylosing spondylitis through a mechanism involving aberrant processing of antigenic peptides.


Nature Genetics | 2011

Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1

Kathryn P. Burdon; Stuart MacGregor; Alex W. Hewitt; Shiwani Sharma; Glyn Chidlow; Richard Ad Mills; Patrick Danoy; Robert J. Casson; Ananth C. Viswanathan; Jimmy Z. Liu; John Landers; Anjali K. Henders; John P. M. Wood; Emmanuelle Souzeau; April Crawford; Paul Leo; Jie Jin Wang; Elena Rochtchina; Dale R. Nyholt; Nicholas G. Martin; Grant W. Montgomery; Paul Mitchell; Matthew A. Brown; David A. Mackey; Jamie E. Craig

We report a genome-wide association study for open-angle glaucoma (OAG) blindness using a discovery cohort of 590 individuals with severe visual field loss (cases) and 3,956 controls. We identified associated loci at TMCO1 (rs4656461[G] odds ratio (OR) = 1.68, P = 6.1 × 10−10) and CDKN2B-AS1 (rs4977756[A] OR = 1.50, P = 4.7 × 10−9). We replicated these associations in an independent cohort of cases with advanced OAG (rs4656461 P = 0.010; rs4977756 P = 0.042) and two additional cohorts of less severe OAG (rs4656461 combined discovery and replication P = 6.00 × 10−14, OR = 1.51, 95% CI 1.35–1.68; rs4977756 combined P = 1.35 × 10−14, OR = 1.39, 95% CI 1.28–1.51). We show retinal expression of genes at both loci in human ocular tissues. We also show that CDKN2A and CDKN2B are upregulated in the retina of a rat model of glaucoma.


The Lancet | 2011

Identification of IL6R and chromosome 11q13.5 as risk loci for asthma

Manuel A. Ferreira; Melanie C. Matheson; David L. Duffy; Guy B. Marks; Jennie Hui; Peter Le Souef; Patrick Danoy; Svetlana Baltic; Dale R. Nyholt; Mark A. Jenkins; Catherine M. Hayden; Gonneke Willemsen; Wei Ang; Mikko Kuokkanen; John Beilby; Faang Cheah; Eco J. C. de Geus; Adaikalavan Ramasamy; Sailaja Vedantam; Veikko Salomaa; Pamela A. F. Madden; Andrew C. Heath; John L. Hopper; Peter M. Visscher; Bill Musk; Stephen Leeder; Marjo-Riitta Järvelin; Craig E. Pennell; Doerret I Boomsma; Joel N. Hirschhorn

BACKGROUND We aimed to identify novel genetic variants affecting asthma risk, since these might provide novel insights into molecular mechanisms underlying the disease. METHODS We did a genome-wide association study (GWAS) in 2669 physician-diagnosed asthmatics and 4528 controls from Australia. Seven loci were prioritised for replication after combining our results with those from the GABRIEL consortium (n=26,475), and these were tested in an additional 25,358 independent samples from four in-silico cohorts. Quantitative multi-marker scores of genetic load were constructed on the basis of results from the GABRIEL study and tested for association with asthma in our Australian GWAS dataset. FINDINGS Two loci were confirmed to associate with asthma risk in the replication cohorts and reached genome-wide significance in the combined analysis of all available studies (n=57,800): rs4129267 (OR 1·09, combined p=2·4×10(-8)) in the interleukin-6 receptor (IL6R) gene and rs7130588 (OR 1·09, p=1·8×10(-8)) on chromosome 11q13.5 near the leucine-rich repeat containing 32 gene (LRRC32, also known as GARP). The 11q13.5 locus was significantly associated with atopic status among asthmatics (OR 1·33, p=7×10(-4)), suggesting that it is a risk factor for allergic but not non-allergic asthma. Multi-marker association results are consistent with a highly polygenic contribution to asthma risk, including loci with weak effects that might be shared with other immune-related diseases, such as NDFIP1, HLA-B, LPP, and BACH2. INTERPRETATION The IL6R association further supports the hypothesis that cytokine signalling dysregulation affects asthma risk, and raises the possibility that an IL6R antagonist (tocilizumab) may be effective to treat the disease, perhaps in a genotype-dependent manner. Results for the 11q13.5 locus suggest that it directly increases the risk of allergic sensitisation which, in turn, increases the risk of subsequent development of asthma. Larger or more functionally focused studies are needed to characterise the many loci with modest effects that remain to be identified for asthma. FUNDING National Health and Medical Research Council of Australia. A full list of funding sources is provided in the webappendix.


PLOS Genetics | 2011

Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk

Emma L. Duncan; Patrick Danoy; John P. Kemp; Paul Leo; Eugene McCloskey; Geoffrey C. Nicholson; Richard Eastell; Richard L. Prince; John A. Eisman; Graeme Jones; P. Sambrook; Ian R. Reid; Elaine M. Dennison; John D. Wark; J.B. Richards; A.G. Uitterlinden; Tim D. Spector; C. Esapa; Roger D. Cox; Steve D.M. Brown; Rajesh V. Thakker; K. Addison; Linda A. Bradbury; C Cooper; C. Cremin; Karol Estrada; Dieter Felsenberg; Claus-C. Glüer; Johanna Hadler; Margaret J. Henry

Osteoporotic fracture is a major cause of morbidity and mortality worldwide. Low bone mineral density (BMD) is a major predisposing factor to fracture and is known to be highly heritable. Site-, gender-, and age-specific genetic effects on BMD are thought to be significant, but have largely not been considered in the design of genome-wide association studies (GWAS) of BMD to date. We report here a GWAS using a novel study design focusing on women of a specific age (postmenopausal women, age 55–85 years), with either extreme high or low hip BMD (age- and gender-adjusted BMD z-scores of +1.5 to +4.0, n = 1055, or −4.0 to −1.5, n = 900), with replication in cohorts of women drawn from the general population (n = 20,898). The study replicates 21 of 26 known BMD–associated genes. Additionally, we report suggestive association of a further six new genetic associations in or around the genes CLCN7, GALNT3, IBSP, LTBP3, RSPO3, and SOX4, with replication in two independent datasets. A novel mouse model with a loss-of-function mutation in GALNT3 is also reported, which has high bone mass, supporting the involvement of this gene in BMD determination. In addition to identifying further genes associated with BMD, this study confirms the efficiency of extreme-truncate selection designs for quantitative trait association studies.


Nature Genetics | 2012

Common variants at 12q14 and 12q24 are associated with hippocampal volume

Joshua C. Bis; Charles DeCarli; Albert V. Smith; Fedde van der Lijn; Fabrice Crivello; Myriam Fornage; Stéphanie Debette; Joshua M. Shulman; Helena Schmidt; Velandai Srikanth; Maaike Schuur; Lei Yu; Seung Hoan Choi; Sigurdur Sigurdsson; Benjamin F.J. Verhaaren; Anita L. DeStefano; Jean Charles Lambert; Clifford R. Jack; Maksim Struchalin; Jim Stankovich; Carla A. Ibrahim-Verbaas; Debra A. Fleischman; Alex Zijdenbos; Tom den Heijer; Bernard Mazoyer; Laura H. Coker; Christian Enzinger; Patrick Danoy; Najaf Amin; Konstantinos Arfanakis

Aging is associated with reductions in hippocampal volume that are accelerated by Alzheimers disease and vascular risk factors. Our genome-wide association study (GWAS) of dementia-free persons (n = 9,232) identified 46 SNPs at four loci with P values of <4.0 × 10−7. In two additional samples (n = 2,318), associations were replicated at 12q14 within MSRB3-WIF1 (discovery and replication; rs17178006; P = 5.3 × 10−11) and at 12q24 near HRK-FBXW8 (rs7294919; P = 2.9 × 10−11). Remaining associations included one SNP at 2q24 within DPP4 (rs6741949; P = 2.9 × 10−7) and nine SNPs at 9p33 within ASTN2 (rs7852872; P = 1.0 × 10−7); along with the chromosome 12 associations, these loci were also associated with hippocampal volume (P < 0.05) in a third younger, more heterogeneous sample (n = 7,794). The SNP in ASTN2 also showed suggestive association with decline in cognition in a largely independent sample (n = 1,563). These associations implicate genes related to apoptosis (HRK), development (WIF1), oxidative stress (MSR3B), ubiquitination (FBXW8) and neuronal migration (ASTN2), as well as enzymes targeted by new diabetes medications (DPP4), indicating new genetic influences on hippocampal size and possibly the risk of cognitive decline and dementia.


PLOS Genetics | 2012

WNT16 influences bone mineral density, cortical bone thickness, bone strength, and osteoporotic fracture risk.

Hou-Feng Zheng; Jon H Tobias; Emma L. Duncan; David Evans; Joel Eriksson; Lavinia Paternoster; Laura M. Yerges-Armstrong; Terho Lehtimäki; Ulrica Bergström; Mika Kähönen; Paul Leo; Olli T. Raitakari; Marika Laaksonen; Geoffrey C. Nicholson; Jorma Viikari; Martin Ladouceur; Leo-Pekka Lyytikäinen; Carolina Medina-Gomez; Fernando Rivadeneira; Richard L. Prince; Harri Sievänen; William D. Leslie; Dan Mellström; John A. Eisman; Sofia Movérare-Skrtic; David Goltzman; David A. Hanley; Graeme Jones; Beate St Pourcain; Yongjun Xiao

We aimed to identify genetic variants associated with cortical bone thickness (CBT) and bone mineral density (BMD) by performing two separate genome-wide association study (GWAS) meta-analyses for CBT in 3 cohorts comprising 5,878 European subjects and for BMD in 5 cohorts comprising 5,672 individuals. We then assessed selected single-nucleotide polymorphisms (SNPs) for osteoporotic fracture in 2,023 cases and 3,740 controls. Association with CBT and forearm BMD was tested for ∼2.5 million SNPs in each cohort separately, and results were meta-analyzed using fixed effect meta-analysis. We identified a missense SNP (Thr>Ile; rs2707466) located in the WNT16 gene (7q31), associated with CBT (effect size of −0.11 standard deviations [SD] per C allele, P = 6.2×10−9). This SNP, as well as another nonsynonymous SNP rs2908004 (Gly>Arg), also had genome-wide significant association with forearm BMD (−0.14 SD per C allele, P = 2.3×10−12, and −0.16 SD per G allele, P = 1.2×10−15, respectively). Four genome-wide significant SNPs arising from BMD meta-analysis were tested for association with forearm fracture. SNP rs7776725 in FAM3C, a gene adjacent to WNT16, was associated with a genome-wide significant increased risk of forearm fracture (OR = 1.33, P = 7.3×10−9), with genome-wide suggestive signals from the two missense variants in WNT16 (rs2908004: OR = 1.22, P = 4.9×10−6 and rs2707466: OR = 1.22, P = 7.2×10−6). We next generated a homozygous mouse with targeted disruption of Wnt16. Female Wnt16−/− mice had 27% (P<0.001) thinner cortical bones at the femur midshaft, and bone strength measures were reduced between 43%–61% (6.5×10−13<P<5.9×10−4) at both femur and tibia, compared with their wild-type littermates. Natural variation in humans and targeted disruption in mice demonstrate that WNT16 is an important determinant of CBT, BMD, bone strength, and risk of fracture.


Arthritis & Rheumatism | 2009

Association of ERAP1, but not IL23R, with ankylosing spondylitis in a Han Chinese population

Stuart I. Davidson; Xin Wu; Yu Liu; Meng Wei; Patrick Danoy; Gethin P. Thomas; Qing Cai; Linyun Sun; Emma L. Duncan; Niansong Wang; Qinghong Yu; Anlong Xu; Yonggui Fu; Matthew A. Brown; Huji Xu

OBJECTIVE The results of a recent genome-wide association study have shown that ERAP1 and IL23R are associated with ankylosing spondylitis (AS) in Caucasian populations from North America and the UK. Based on these findings, we undertook the current study to investigate whether single-nucleotide polymorphisms (SNPs) covering the genes ERAP1 and IL23R are associated with AS in a Han Chinese population. METHODS A case-control study was performed in Han Chinese patients with AS (n = 527) and controls (n = 945) from Shanghai and Nanjing. All patients met the modified New York criteria for AS. The Sequenom iPlex platform was used to genotype cases and controls for 21 tag SNPs covering IL23R and 38 tag SNPs covering ERAP1. Statistical analysis was performed using the Cochran-Armitage test for trend. RESULTS Multiple SNPs in ERAP1 were significantly associated with AS (for rs27980, P = 0.0048; for rs7711564, P = 0.0081). However, no association was observed between IL23R and AS (for all SNPs, P > 0.1). The nonsynonymous SNP in IL23R, rs11209026, widely thought to be the primary AS-associated SNP in IL23R in Europeans, was found not to be polymorphic in Chinese. CONCLUSION Our results demonstrate that genetic polymorphisms in ERAP1 are associated with AS in Han Chinese, suggesting a common pathogenic mechanism for the disease in Chinese and Caucasian populations, and that IL23R is not associated with AS in Chinese, indicating a difference in the mechanism of disease pathogenesis between Chinese and Caucasian populations. This may result from the fact that rs11209026, the nonsynonymous SNP in IL23R, is not polymorphic in Chinese patients, providing further evidence that rs11209026 is the key polymorphism associated with AS (and likely inflammatory bowel disease and psoriasis) in this gene.


The Journal of Allergy and Clinical Immunology | 2014

Genome-wide association analysis identifies 11 risk variants associated with the asthma with hay fever phenotype.

Manuel A. Ferreira; Melanie C. Matheson; Clara S. Tang; Raquel Granell; Wei Ang; Jennie Hui; Amy K. Kiefer; David L. Duffy; Svetlana Baltic; Patrick Danoy; Minh Bui; Loren Price; Peter D. Sly; Nicholas Eriksson; Pamela A. F. Madden; Michael J. Abramson; Patrick G. Holt; Andrew C. Heath; Michael Hunter; Bill Musk; Colin F. Robertson; Peter Le Souef; Grant W. Montgomery; A. John Henderson; Joyce Y. Tung; Shyamali C. Dharmage; Matthew A. Brown; Alan James; Philip J. Thompson; Craig E. Pennell

BACKGROUND To date, no genome-wide association study (GWAS) has considered the combined phenotype of asthma with hay fever. Previous analyses of family data from the Tasmanian Longitudinal Health Study provide evidence that this phenotype has a stronger genetic cause than asthma without hay fever. OBJECTIVE We sought to perform a GWAS of asthma with hay fever to identify variants associated with having both diseases. METHODS We performed a meta-analysis of GWASs comparing persons with both physician-diagnosed asthma and hay fever (n = 6,685) with persons with neither disease (n = 14,091). RESULTS At genome-wide significance, we identified 11 independent variants associated with the risk of having asthma with hay fever, including 2 associations reaching this level of significance with allergic disease for the first time: ZBTB10 (rs7009110; odds ratio [OR], 1.14; P = 4 × 10(-9)) and CLEC16A (rs62026376; OR, 1.17; P = 1 × 10(-8)). The rs62026376:C allele associated with increased asthma with hay fever risk has been found to be associated also with decreased expression of the nearby DEXI gene in monocytes. The 11 variants were associated with the risk of asthma and hay fever separately, but the estimated associations with the individual phenotypes were weaker than with the combined asthma with hay fever phenotype. A variant near LRRC32 was a stronger risk factor for hay fever than for asthma, whereas the reverse was observed for variants in/near GSDMA and TSLP. Single nucleotide polymorphisms with suggestive evidence for association with asthma with hay fever risk included rs41295115 near IL2RA (OR, 1.28; P = 5 × 10(-7)) and rs76043829 in TNS1 (OR, 1.23; P = 2 × 10(-6)). CONCLUSION By focusing on the combined phenotype of asthma with hay fever, variants associated with the risk of allergic disease can be identified with greater efficiency.


Human Molecular Genetics | 2010

The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis

Kaushal S. Gandhi; Fiona C. McKay; Mathew B. Cox; Carlos Riveros; Nicola J. Armstrong; Robert Heard; Steve Vucic; David W. Williams; Jim Stankovich; Matthew A. Brown; Patrick Danoy; Graeme J. Stewart; Simon Broadley; Pablo Moscato; Jeannette Lechner-Scott; Rodney J. Scott; David R. Booth

Multiple sclerosis (MS) is an autoimmune disease with a genetic component, caused at least in part by aberrant lymphocyte activity. The whole blood mRNA transcriptome was measured for 99 untreated MS patients: 43 primary progressive MS, 20 secondary progressive MS, 36 relapsing remitting MS and 45 age-matched healthy controls. The ANZgene Multiple Sclerosis Genetics Consortium genotyped more than 300 000 SNPs for 115 of these samples. Transcription from genes on translational regulation, oxidative phosphorylation, immune synapse and antigen presentation pathways was markedly increased in all forms of MS. Expression of genes tagging T cells was also upregulated (P < 10(-12)) in MS. A T cell gene signature predicts disease state with a concordance index of 0.79 with age and gender as co-variables, but the signature is not associated with clinical course or disability. The ANZgene genome wide association screen identified two novel regions with genome wide significance: one encoding the T cell co-stimulatory molecule, CD40; the other a region on chromosome 12q13-14. The CD40 haplotype associated with increased MS susceptibility has decreased gene expression in MS (P < 0.0007). The second MS susceptibility region includes 17 genes on 12q13-14 in tight linkage disequilibrium. Of these, only 13 are expressed in leukocytes, and of these the expression of one, FAM119B, is much lower in the susceptibility haplotype (P < 10(-14)). Overall, these data indicate dysregulation of T cells can be detected in the whole blood of untreated MS patients, and supports targeting of activated T cells in therapy for all forms of MS.


Annals of the Rheumatic Diseases | 2011

Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese

Stuart I. Davidson; Yu Liu; Patrick Danoy; Xin Wu; Gethin P. Thomas; Lei Jiang; Linyun Sun; Niansong Wang; Jun Han; Huanxing Han; Peter M. Visscher; Matthew A. Brown; Huji Xu

Objectives Recent association studies by the Australo-Anglo-American Spondyloarthritis Consortium (TASC) in Caucasian European populations from Australia, North America and the UK have identified a number of genes as being associated with ankylosing spondylitis (AS). A candidate gene study in a Han Chinese population was performed based on these findings to identify associated genes in this population. Methods A case-control study was performed in a Han Chinese population of patients with AS (n=775) and controls (n=1587) from Shanghai and Nanjing. All patients met the modified New York criteria for AS. The cases and controls were genotyped for 115 single nucleotide polymorphisms (SNPs) tagging IL23R, ERAP1, STAT3, JAK2, TNFRSF1A and TRADD, as well as other confirmation SNPs from the TASC study, using the Sequenom iPlex and the ABI OpenArray platforms. Statistical analysis of genotyped SNPs was performed using the Cochran–Armitage test for trend and meta-analysis was performed using METAL. SNPs in AS-associated genes in this study were then imputed using MaCH, and association with AS tested by logistic regression. Results SNPs in TNFRSF1A (rs4149577, p=8.2×10−4), STAT3 (rs2293152, p=0.0015; rs1053005, p=0.017) and ERAP1 (rs27038, p=0.0091; rs27037, p=0.0092) were significantly associated with AS in Han Chinese. Association was also observed between AS and the intergenic region 2p15 (rs10865331, p=0.023). The lack of association between AS and IL23R in Han Chinese was confirmed (all SNPs p>0.1). Conclusions The study results demonstrate for the first time that genetic polymorphisms in STAT3, TNFRSF1A and 2p15 are associated with AS in Han Chinese, suggesting common pathogenic mechanisms for the disease in Chinese and Caucasian European populations. Furthermore, previous findings demonstrating that ERAP1, but not IL23R, is associated with AS in Chinese patients were confirmed.

Collaboration


Dive into the Patrick Danoy's collaboration.

Top Co-Authors

Avatar

Matthew A. Brown

Queensland University of Technology

View shared research outputs
Top Co-Authors

Avatar

Huji Xu

Second Military Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Emma L. Duncan

Queensland University of Technology

View shared research outputs
Top Co-Authors

Avatar

Paul Leo

Queensland University of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Xin Wu

Second Military Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

L. Jiang

Imperial College London

View shared research outputs
Researchain Logo
Decentralizing Knowledge